AD carriers of H63D mutation in the HFE exhibited increased levels of iron and decreased levels of transferrin and ceruloplasmin, resembling hemochromatosis, which was not found in H63D non-carrier AD patients, suggesting that carrying the H63D mutation seems not to be itself sufficient to increase the risk of AD. This evidence concerns the gene TF and hemochromatosis type 1.